📚 Data Dive

Charting the Future: Why EHR is the Backbone of Modern Medicine

Electronic Health Records (EHR) have evolved from basic data repositories into a cornerstone of modern healthcare, driving operational efficiency, enhancing patient care, and meeting increasingly complex regulatory requirements. The global EHR market is poised for significant growth, with projections rising from $28.8 billion in 2023 to $45.7 billion by 2033, a testament to its critical role in the healthcare ecosystem.

This report delves into the dynamics shaping the EHR sector, from rapid adoption trends to emerging investment opportunities. It highlights the drivers behind its expansion—technological advancements like AI, regulatory mandates, and the shift toward value-based care, while analyzing challenges such as high implementation costs and data security concerns.

Whether you’re tracking market leaders like Epic and Oracle Cerner or exploring investment opportunities in interoperability and AI-driven solutions, this report equips you with insights to navigate the evolving EHR landscape. Stay ahead of the curve in a sector where innovation is not just an option, it’s essential.

Want to learn more?

📈 Trend of the Week

Procedure Utilization: A Slow Return to Normalcy

Procedure utilization rates for both commercial insurance and Medicare fee-for-service remain below pre-pandemic levels, signaling a notable shift in healthcare consumption patterns. Commercial insurance saw a 7% decline in procedures  between 2019 and 2023, while Medicare fee-for-service dropped by 2.4% over the same period. These trends suggest that factors such as delayed care, lingering patient hesitancy, and changes in care delivery models are still disrupting the recovery to 2019 levels.

For high-level investors, this data underscores both a challenge and an opportunity. While the reduced utilization may temper short-term revenue growth for providers and payers, it also highlights areas ripe for innovation and disruption. Providers who adopt strategies to proactively re-engage patients, through virtual care, preventive services, or improved care access, stand to capture untapped demand. Similarly, investment in technology-driven solutions, such as data analytics and patient engagement platforms, could reshape the utilization landscape and position stakeholders to thrive in a post-pandemic healthcare economy.

📊 Market Movers

⚕️ HealthTech Corner

AI in Health Tech: Big Bets, Bigger Valuations

Health tech is riding the AI wave—and valuations are soaring. AI-focused companies now command a staggering 38% of health tech funding in 2024, up from 29% in 2022. At 30-50x EV/ARR multiples, AI deals are valued 2-5x higher than their non-AI peers, signaling private market enthusiasm for this transformative tech.

Mega rounds, including $150M for Abridge (AI scribes) and $111M for Zephyr AI (PharmaTech), highlight investor confidence in categories like RCM automation and clinical back-office AI. Why? Providers, payers, and pharma are all in on AI’s potential to deliver measurable ROI through new efficiencies and outcomes.

The emerging “AI Services-as-Software” model exemplifies this shift. Unlike traditional SaaS or tech-enabled clinical services, these companies autonomously handle complex tasks with minimal human oversight, offering clients not just tools but results. As benchmarks evolve, expect AI to redefine scaling in health tech.

The bottom line: AI isn’t just transforming healthcare—it’s reshaping its entire economic engine.

🤝 Deal of the Week

Allstate Sells Group Health Business to Nationwide for $1.25B

In a move to streamline operations and maximize shareholder value, Allstate has agreed to sell its Group Health business to Nationwide for $1.25 billion in cash, pending regulatory approval. The Group Health segment, which provides stop-loss insurance to small businesses, generated $608 million in revenue and $69 million in adjusted net income in the first nine months of 2024. Nationwide plans to integrate these offerings into its existing portfolio to expand its product range and distribution capabilities.

This deal is part of a broader strategy by Allstate, which also sold its Employer Voluntary Benefits unit to StanCorp Financial Group for a combined total of $3.25 billion in proceeds. While the sale will generate a $450 million financial book gain and increase Allstate’s deployable capital by $0.9 billion, it will slightly reduce adjusted net income return on equity. Originally acquired in the 2021 $4 billion purchase of National General, the Group Health business now finds a more strategically aligned home at Nationwide, underscoring the growing demand for specialized insurance solutions.

Love Healthcare150? Receive the Same Weekly Newsletter For the Private Equity Market!

PE150 delivers proprietary insights, market trends, and actionable tools for Private Equity & M&A professionals—in just one 5 minute weekly email. Subscribe now

📍 Regional Focus

Bed Density Disparities: Where Demand Meets High-Impact Investment

Healthcare infrastructure is the backbone of any functional healthcare system, and bed density is a critical metric that exposes both strengths and vulnerabilities in emerging markets. As seen in the chart, Russia sets the benchmark with 70 beds per 10,000 people, while China (43) and Vietnam (26) trail significantly. At the opposite end, India (15) and Bangladesh (8) highlight the stark challenges of underdeveloped infrastructure in high-demand regions.

For high-level investors, these gaps represent a rare intersection of necessity and opportunity. From private hospital expansion to scalable care delivery models, the healthcare sector in these markets is primed for transformative growth. Bridging these capacity gaps isn't just about addressing unmet needs—it’s about positioning investments where demand and impact align for exponential returns. In a rapidly evolving healthcare landscape, this is where innovation meets capital.

📰 Interesting Articles

"The way to get started is to quit talking and begin doing"

Walt Disney